Following months of financial uncertainty, Isagenix has been sold to a group of undisclosed investors.

Isagenix’s financial troubles have been brewing in the background for a while.

This is from a
September 2022 Moody’s report
;

Moody’s believes a deterioration in member base and weakening consumer demand is contributing to revenue declines, which combined with inflationary cost pressures is leading to significant EBITDA erosion.

Isagenix’s cash on hand of $19 million as of June 2022 is insufficient to repay the $29 million of revolver borrowings and term loan amortization of $18.8 million over the next 12 months.

Moody’s anticipates ongoing headwinds in the company’s recruiting efforts to continue.

Isagenix’s current capital structure is unsustainable, prompting Moody’s expectations of a rising likelihood of near-term restructuring and that the company will unlikely be able to raise sufficient new funds to refinance the maturing debt at a manageable interest cost.

That predicted restructuring was announced by Isagenix on February 27th;

Isagenix International … announced today that it has reached a definitive agreement with an ad hoc group of the Company’s investors to secure the long term future of the business.

This agreement, also known as a Restructuring Support Agreement or “RSA,” marks the positive culmination of discussions between the Company and its key financial stakeholders to recapitalize and support the business, eliminating approximately
$130 million
 in senior secured debt.

Under the terms of the RSA, the Company’s investors will take a controlling stake in the business. (The) Coover family … will maintain minority ownership.

In addition to the cash injection, Isagenix co-founders Jim (right) and Kathy Coover are contributing

$95 million
of value through the combination of new contributed cash and the forgiveness of debt.

Isagenix has also secured an additional $130 million in debt reduction from other secured lenders.

🤖 Quick Answer

What led to Isagenix's sale to undisclosed investors?
Isagenix faced severe financial deterioration including declining member base, weakening consumer demand, and significant EBITDA erosion. With only $19 million in cash against $47.8 million in debt obligations due within twelve months, the company's capital structure became unsustainable, necessitating the sale.

What financial indicators signaled Isagenix's distress?
Moody's September 2022 report documented revenue declines, inflationary cost pressures, and insufficient liquidity. The company possessed merely $19 million cash reserves against combined revolver borrowings of $29 million and term loan amortization of $18.8 million due within one year.

How did market conditions impact Isagenix's operations?
Deteriorating member recruitment efforts, weakening consumer demand, and inflat

🔗 Related Articles

- Capitalvest Pro Review: 25% in 14 days Ponzi scheme
- Empic Review: HYIP Customize Ponzi scheme
- OBC AI Review: Quantitative trading “click a button” app Ponzi
- BitArbi Review: Crypto trading ruse Ponzi scheme
- Espian Global Review: This scam has nothing to do with ESPN